These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2735232)

  • 21. [Measurement of serum tissue-polypeptide antigen (TPA) levels by EIA employing monoclonal antibody].
    Takami H
    Gan To Kagaku Ryoho; 1994 May; 21(6):853-8. PubMed ID: 8185344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of urinary tissue polypeptide specific antigen (TPS) determination in patients with urothelial carcinoma.
    Yao WJ; Chang CJ; Chan SH; Chow NH; Cheng HL; Tzai TS; Lin SN
    Anticancer Res; 1995; 15(6B):2819-23. PubMed ID: 8669871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue polypeptide antigen (TPA): usefulness in urological neoplasia.
    Costello CB; Kumar S
    Anticancer Res; 1986; 6(4):713-6. PubMed ID: 3752950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinical value of tissue polypeptide antigen in ovarian carcinoma].
    Wu L; Sun J; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental and clinical studies on a TPA kit, Prolifigen].
    Ayabe Z; Ichiya Y; Yamaguchi I; Kuwabara Y; Wada M; Katsuragi M; Matsuura K
    Radioisotopes; 1985 Apr; 34(4):230-3. PubMed ID: 4023281
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
    Kazama T; Katayama T; Yamazaki N
    Hinyokika Kiyo; 1985 Dec; 31(12):2113-9. PubMed ID: 3832915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of BEKI TPS radioassay kit as a one-step immunoradiometric assay utilizes monoclonal and polyclonal antibodies specific for serum tissue polypeptide antigen].
    Hamase A; Kawanaka M; Kitani H; Fukuchi M
    Kaku Igaku; 1994 Aug; 31(8):995-1003. PubMed ID: 7933689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of the cut-off for marker TPA in healthy children].
    Magrì G; Giargia L
    Minerva Pediatr; 1994 Nov; 46(11):517-9. PubMed ID: 7870010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer.
    Bennink R; Van Poppel H; Billen J; Decoster M; Baert L; Mortelmans L; Blanckaert N
    Anticancer Res; 1999; 19(4A):2609-13. PubMed ID: 10470203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tissue polypeptide antigen (TPA) in non-neoplastic diseases].
    Ruibal A; Durán Bellido P; Salgado A; García Bragado F; Monné J; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):421-5. PubMed ID: 6546171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients.
    Kumar S; Costello CB; Glashan RW; Björklund B
    Br J Urol; 1981 Dec; 53(6):578-81. PubMed ID: 7317745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
    Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
    Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
    Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
    Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
    Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H
    Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TPA prognostic value in superficial bladder cancer.
    Filella X; Menendez V; Molina R; Alcover J; Carretero P; Ballesta AM
    Anticancer Res; 1996; 16(4B):2173-5. PubMed ID: 8694539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of a lung cancer-associated protein antigen, cytokeratin 19 fragment: I. Radioimmunoassay and its fundamental character for clinical laboratory measurement].
    Kubo N; Gang Y; Okuno M; Sakurabayashi I
    Rinsho Byori; 1993 Oct; 41(10):1173-8. PubMed ID: 7504754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.